- Sandoz's ANDA cannot be approved until after all patents expire in 2033
- Omeros previously settled lawsuits against Par and Lupin
Omeros Corporation (Nasdaq: OMER)... read more
Omeros Corporation (Nasdaq: OMER)... read more
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,